Healthcare & Pharmaceuticals Industry Press Releases

Published on April 25, 2024 - 12:00 GMT

Promising perspectives for the application of SDS Optic’s inPROBE technology platform for protein expression determination

LUBLIN, Poland, April 25, 2024 (GLOBE NEWSWIRE) -- An inherent feature of oncology is personalization, i.e., conversion from the fit-to-all strategy based on applying the same chemotherapy regimens to all patients with a specific type of cancer to therapy …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on April 25, 2024 - 12:00 GMT

Cerevance Adds $47 Million in Series B-1 Extension to Advance Robust Clinical Pipeline

Financing round led by Agent Capital, Bioluminescence, and Double Point Ventures, with participation from new investors MQB Partners and others Proceeds will advance Cerevance’s first-in-class pre-clinical and clinical programs, including initiation of the …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on April 25, 2024 - 12:00 GMT

ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, ...

Garden City, NY, April 25, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a biopharma, genomics and diagnostics Company, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 at 11:30 …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on April 25, 2024 - 12:00 GMT

Collegium to Report First Quarter 2024 Financial Results on May 9, 2024

STOUGHTON, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on April 25, 2024 - 12:00 GMT

Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024

SEATTLE and VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on April 25, 2024 - 12:00 GMT

Compass Therapeutics Receives FDA Fast Track Designation for the Investigation of CTX-009 in Combination with Paclitaxel for the ...

CTX-009, the Company’s bispecific DLL4/VEGF-A antibody, in combination with paclitaxel, has shown promising clinical responses in patients with advanced biliary tract cancer (BTC) in its Phase 2 study Top-line data readout for COMPANION-002, the Company’s …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on April 25, 2024 - 12:00 GMT

Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference ...

WARREN, N.J., April 25, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on April 25, 2024 - 12:00 GMT

Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held ...

BOCA RATON, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, reminds investors that …

Distribution channels:

Published on April 25, 2024 - 12:00 GMT

Tilray Brands Celebrates Epic 420 Weekend With Over 20,000 Fans Across the U.S.

NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (Nasdaq | TSX: TLRY), a premier global leader in the cannabis-lifestyle and consumer packaged goods industry, celebrated 420 with an unprecedented display of community …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on April 25, 2024 - 12:00 GMT

BioStem Technologies to Present at the 2024 Planet MicroCap Showcase

POMPANO BEACH, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on April 25, 2024 - 12:00 GMT

AssistRx Launches Advanced Access Anywhere to Expedite Access and Automate Enrollment at the Point of Pharmacy Claim

ORLANDO, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- AssistRx, the advanced therapy initiation and patient solutions provider, today launched Advanced Access Anywhere (AAA), a first-of-its-kind solution designed to accelerate therapy initiation and automate …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on April 25, 2024 - 12:00 GMT

FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids

HOUSTON, April 25, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics") and Charles River Laboratories (“Charles River”), a highly respected, global provider of drug discovery, development, and manufacturing solutions, …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on April 25, 2024 - 12:00 GMT

Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MD

SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on April 25, 2024 - 12:00 GMT

DiagnaMed’s BRAIN AGE® Brain Health AI Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper

TORONTO, April 25, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, today announced a clinical validation milestone of the BRAIN …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on April 25, 2024 - 12:00 GMT

BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore Homeostasis in a Manner ...

“Bezisterim” has been approved as the non-proprietary name for NE3107 Data shows how bezisterim may be restoring homeostasis via specific genes associated with dementia, metabolism, and inflammation CARSON CITY, Nev., April 25, 2024 (GLOBE NEWSWIRE) -- …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on April 25, 2024 - 12:00 GMT

UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting

SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that the Company will present …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on April 25, 2024 - 12:00 GMT

Tracy Culleton appointed Executive Director of Autism Speaks Canada

Toronto, April 25, 2024 (GLOBE NEWSWIRE) -- Autism Speaks Canada, a national charity dedicated to creating an inclusive Canada for all individuals with autism throughout their lifespan, announced the appointment of Tracy Culleton as its Executive Director. …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on April 25, 2024 - 12:00 GMT

Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024

SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the close …

Distribution channels:

Published on April 25, 2024 - 11:30 GMT

Jushi Holdings Inc. to Report First Quarter 2024 Financial Results on May 9, 2024

BOCA RATON, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the first …

Distribution channels:

Published on April 25, 2024 - 11:30 GMT

Kura Oncology to Report First Quarter 2024 Financial Results

SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will report first …

Distribution channels:

Healthcare & Pharmaceuticals Industry Press Releases Distributed by EIN Presswire